<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">epilepsia</journal-id><journal-title-group><journal-title xml:lang="en">Epilepsy and paroxysmal conditions</journal-title><trans-title-group xml:lang="ru"><trans-title>Эпилепсия и пароксизмальные состояния</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2077-8333</issn><issn pub-type="epub">2311-4088</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">epilepsia-47</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group></article-categories><title-group><article-title></article-title><trans-title-group xml:lang="ru"><trans-title>ЭФФЕКТ ПЛАЦЕБО И ЭПИЛЕПСИЯ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Давыдов</surname><given-names>О. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Davydov</surname><given-names>О. S.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт общей патологии и патофизиологии Российской академии медицинских наук, Москва</institution><country>Россия</country></aff><aff xml:lang="en"><institution>The Institute of General Pathology and Pathophysiology, Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>02</day><month>06</month><year>2016</year></pub-date><volume>6</volume><issue>3</issue><fpage>50</fpage><lpage>53</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Davydov О.S., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Давыдов О.С.</copyright-holder><copyright-holder xml:lang="en">Davydov О.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.epilepsia.su/jour/article/view/47">https://www.epilepsia.su/jour/article/view/47</self-uri><trans-abstract xml:lang="ru"><p>.</p></trans-abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Perkins B.D. The Influence of Metallic Tractors on the Human Body, in removing various painful inflammatory diseases, such as rheumatism, pleurisy, some gouty affections, &amp;c. &amp;c.: Lately discovered by Dr. Perkins, of North America, and demonstrated in a series of experiments and observations, by professors Meigs, Woodward, Rogers, &amp;c. &amp;c.: by which the importance of the discovery is fully ascertained, and a new field of enquiry opened in the modern science of galvanism, or, animal electricity. 1798; Printed for J. Johnson and Ogilvy and Son, London; Reprint: ECCO (Eighteenth Century Collections Online) Print Editions 2011, LaVergne, Tennessee.</mixed-citation><mixed-citation xml:lang="en">Perkins B.D. The Influence of Metallic Tractors on the Human Body, in removing various painful inflammatory diseases, such as rheumatism, pleurisy, some gouty affections, &amp;c. &amp;c.: Lately discovered by Dr. Perkins, of North America, and demonstrated in a series of experiments and observations, by professors Meigs, Woodward, Rogers, &amp;c. &amp;c.: by which the importance of the discovery is fully ascertained, and a new field of enquiry opened in the modern science of galvanism, or, animal electricity. 1798; Printed for J. Johnson and Ogilvy and Son, London; Reprint: ECCO (Eighteenth Century Collections Online) Print Editions 2011, LaVergne, Tennessee.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Haygarth J. Of the imagination, as a cause and as a cure of disorders of the body; exemplified by fictitious tractors, and epidemical convulsions. Read to the literary and philosophical society of bath. 1800; Bath, Cruttwell; Reprint: ECCO [Eighteenth Century Collections Online] Print Editions 2011, LaVergne, Tennessee.</mixed-citation><mixed-citation xml:lang="en">Haygarth J. Of the imagination, as a cause and as a cure of disorders of the body; exemplified by fictitious tractors, and epidemical convulsions. Read to the literary and philosophical society of bath. 1800; Bath, Cruttwell; Reprint: ECCO [Eighteenth Century Collections Online] Print Editions 2011, LaVergne, Tennessee.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">https://www.placeboeffect.com.</mixed-citation><mixed-citation xml:lang="en">https://www.placeboeffect.com.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Shapiro A. The placebo effect. In: Principles of Psychopharmacology. N.Y. 1978; 441-459.</mixed-citation><mixed-citation xml:lang="en">Shapiro A. The placebo effect. In: Principles of Psychopharmacology. N.Y. 1978; 441-459.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Лапин И.П. Плацебо и терапия. Спб. 2000; 8-12, 46-49.</mixed-citation><mixed-citation xml:lang="en">Лапин И.П. Плацебо и терапия. Спб. 2000; 8-12, 46-49.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Amanzio M., Pollo A., Maggi G., Benedetti F. Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain. 2001 Feb; 15; 90 (3): 205-15.</mixed-citation><mixed-citation xml:lang="en">Amanzio M., Pollo A., Maggi G., Benedetti F. Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain. 2001 Feb; 15; 90 (3): 205-15.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Haltia L.T., Rinne J.O., Helin S., Parkkola R., Nagren K., Kaasinen V. Effects of intravenous placebo with glucose expectation on human basal ganglia dopaminergic function. Synapse. 2008; 62 (9): 682-8.</mixed-citation><mixed-citation xml:lang="en">Haltia L.T., Rinne J.O., Helin S., Parkkola R., Nagren K., Kaasinen V. Effects of intravenous placebo with glucose expectation on human basal ganglia dopaminergic function. Synapse. 2008; 62 (9): 682-8.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Petrovic P., Kalso E., Petersson K.M., Ingvar M. Placebo and opioid analgesia-imaging a shared neuronal network. Science. 2002 Mar 1; 295 (5560): 1737-40.</mixed-citation><mixed-citation xml:lang="en">Petrovic P., Kalso E., Petersson K.M., Ingvar M. Placebo and opioid analgesia-imaging a shared neuronal network. Science. 2002 Mar 1; 295 (5560): 1737-40.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Murray D., Stoessl A.J. Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions, Pharmacol. Ther. 2013 Dec; 140 (3): 306-18.</mixed-citation><mixed-citation xml:lang="en">Murray D., Stoessl A.J. Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions, Pharmacol. Ther. 2013 Dec; 140 (3): 306-18.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Marson A.G., Kadir Z.A., Chadwick D.W. New antiepileptic drugs: a systematic review of their efficacy and tolerability. BMJ. 1996 Nov 9; 313 (7066): 1169-74.</mixed-citation><mixed-citation xml:lang="en">Marson A.G., Kadir Z.A., Chadwick D.W. New antiepileptic drugs: a systematic review of their efficacy and tolerability. BMJ. 1996 Nov 9; 313 (7066): 1169-74.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Burneo J.G., Montori V.M., Faught E. Magnitude of the placebo effect in randomized trials of antiepileptic agents. Epilepsy Behav. 2002; 3: 532-4.</mixed-citation><mixed-citation xml:lang="en">Burneo J.G., Montori V.M., Faught E. Magnitude of the placebo effect in randomized trials of antiepileptic agents. Epilepsy Behav. 2002; 3: 532-4.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Beyenburg S., Stavem K., Schmidt D. Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta-analysis. Epilepsia. 2010; 51: 7-26.</mixed-citation><mixed-citation xml:lang="en">Beyenburg S., Stavem K., Schmidt D. Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta-analysis. Epilepsia. 2010; 51: 7-26.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Guekht A.B., Korczyn A.D., Bondareva I.B., Gusev E.I. Placebo responses in randomized trials of antiepileptic drugs. Epilepsy Behav. 2010; 17: 64-9.</mixed-citation><mixed-citation xml:lang="en">Guekht A.B., Korczyn A.D., Bondareva I.B., Gusev E.I. Placebo responses in randomized trials of antiepileptic drugs. Epilepsy Behav. 2010; 17: 64-9.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Rheims S., Cucherat M., Arzimanoglou A., Ryvlin P. Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy. PLoS Med. 2008 Aug 12; 5 (8): e166.</mixed-citation><mixed-citation xml:lang="en">Rheims S., Cucherat M., Arzimanoglou A., Ryvlin P. Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy. PLoS Med. 2008 Aug 12; 5 (8): e166.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Tachibana Y., Narukawa M. Investigation of influencing factors on higher placebo response in East Asian versus Western clinical trials for partial epilepsy: a meta-analysis. Clin Drug Investig. 2013 May; 33(5): 315-24.</mixed-citation><mixed-citation xml:lang="en">Tachibana Y., Narukawa M. Investigation of influencing factors on higher placebo response in East Asian versus Western clinical trials for partial epilepsy: a meta-analysis. Clin Drug Investig. 2013 May; 33(5): 315-24.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Pollo A., Benedetti F. The placebo response: neurobiological and clinical issues of neurological relevance. Prog Brain Res. 2009; 175: 283-94.</mixed-citation><mixed-citation xml:lang="en">Pollo A., Benedetti F. The placebo response: neurobiological and clinical issues of neurological relevance. Prog Brain Res. 2009; 175: 283-94.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Thomas K.B. General practice consultations: is there any point in being positive? Br Med J. 1987; 294: 1200-1202.</mixed-citation><mixed-citation xml:lang="en">Thomas K.B. General practice consultations: is there any point in being positive? Br Med J. 1987; 294: 1200-1202.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Amanzio M., Pollo A., Maggi G., Benedetti F. Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain. 2001 Feb15; 90 (3): 205-15.</mixed-citation><mixed-citation xml:lang="en">Amanzio M., Pollo A., Maggi G., Benedetti F. Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain. 2001 Feb15; 90 (3): 205-15.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Branthwaite A., Cooper P. Analgesic effects of branding in treatment of headaches. Br Med J (Clin Res Ed). 1981 May 16; 282 (6276): 1576-8.</mixed-citation><mixed-citation xml:lang="en">Branthwaite A., Cooper P. Analgesic effects of branding in treatment of headaches. Br Med J (Clin Res Ed). 1981 May 16; 282 (6276): 1576-8.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Schmidt D., Beyenburg S., DSouza J., Stavem K. Clinical features associated with placebo response in refractory focal epilepsy. Epilepsy Behav. 2013; 27: 393-398.</mixed-citation><mixed-citation xml:lang="en">Schmidt D., Beyenburg S., DSouza J., Stavem K. Clinical features associated with placebo response in refractory focal epilepsy. Epilepsy Behav. 2013; 27: 393-398.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">French J., Brandt C., Friedman D., Biton V., Knapp L., Pitman V., Chew M., Dubrava S., Posner H.B. Adjunctive use of controlled-release pregabalin in adults with treatment-resistant partial seizures: A double-blind, randomized, placebo-controlled trial. Epilepsia. 2014 Jun 24. doi: 10.1111/epi.12690. [Epub ahead of print].</mixed-citation><mixed-citation xml:lang="en">French J., Brandt C., Friedman D., Biton V., Knapp L., Pitman V., Chew M., Dubrava S., Posner H.B. Adjunctive use of controlled-release pregabalin in adults with treatment-resistant partial seizures: A double-blind, randomized, placebo-controlled trial. Epilepsia. 2014 Jun 24. doi: 10.1111/epi.12690. [Epub ahead of print].</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Arnold L.M., Arsenault P., Huffman C., Patrick J.L., Messig M., Chew M.L., Sanin L., Scavone J.M., Pauer L., Clair A.G. Once-daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a Phase III, double-blind, randomized withdrawal, placebo-controlled study. Curr Med Res Opin. 2014 May 27; 1-35.</mixed-citation><mixed-citation xml:lang="en">Arnold L.M., Arsenault P., Huffman C., Patrick J.L., Messig M., Chew M.L., Sanin L., Scavone J.M., Pauer L., Clair A.G. Once-daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a Phase III, double-blind, randomized withdrawal, placebo-controlled study. Curr Med Res Opin. 2014 May 27; 1-35.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">http://www.clinicaltrials.gov/ct2/results?term=pregabalin+CR&amp;Search=Search.</mixed-citation><mixed-citation xml:lang="en">http://www.clinicaltrials.gov/ct2/results?term=pregabalin+CR&amp;Search=Search.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
